Advanced Micro Devices, Inc. (AMD)

The panel's take

Verdict: WAIT · Conviction: MEDIUM · Last price: USD 466.38 (as of 2026-06-06)

The panel is divided in signal but unusually aligned in substance: almost every framework agrees AMD is a high-quality, fast-accelerating business — and that at roughly 60–70x forward earnings the stock already prices in years of perfect execution. Bulls and bears alike point to the same single fact, valuation, and reach opposite conclusions, which is why the synthesized read lands on WAIT rather than a directional call.

Key levels

Key resistance sits at the recent all-time high near USD 546, with a supply zone around 520–530; key support runs from the 5-week moving-average area near 451 down through a historical accumulation zone around 415–437, and the analyst consensus target spans roughly USD 250 to 665 with an average near USD 478.

What legendary investors think

We ran Advanced Micro Devices past a panel of six legendary investors' frameworks.

Where they agree — and where they clash

Common ground

• The underlying business is genuinely excellent and accelerating: Q1 2026 revenue +38% YoY to $10.3B, data center +57% to $5.8B, record $2.6B quarterly free cash flow.
• The balance sheet is a fortress — debt/equity ~0.06, ~$9B net cash — and management execution under Lisa Su is widely respected.
• Valuation is the central tension: at ~60–70x forward earnings, the price embeds years of flawless execution.

The real debate

• What's priced in: The Disruptive-Innovation Seeker sees a PEG near 1.26 against a $500B+ TAM as room to run, while the Intrinsic-Value Modeler's DCF says the same price already requires the bull case to become the base case (fair value ~USD 280–320).
• The moat: The Moat Compounder and Forensic Skeptic see a contested position (NVIDIA's CUDA ecosystem, ~80% GPU share) with no asset floor — ~33x tangible book — whereas the Disruptive-Innovation Seeker and Macro Opportunist see AMD as the credible #2 in a market where the #1 can't supply all demand.
• Timing vs. value: The Macro Opportunist is high-conviction on the thesis but wants a pullback to the 415–437 zone for a better setup, while the Forensic Skeptic and Intrinsic-Value Modeler argue the gap to intrinsic value is structural, not a timing question.

The question it comes down to: Is AMD's accelerating AI franchise durable enough to grow into a ~60–70x forward multiple — or does a business at ~6% GPU share and ~8.7% GAAP ROE, priced for perfection, leave too little room for any stumble?

The numbers

Metric	Value
Price / Market cap	USD 466.38 / ~760B
P/E (TTM / fwd)	~178x / ~60–70x
ROE	8.68%
Operating margin	~11% GAAP (~25% non-GAAP)
Dividend yield	0% (no dividend)
Debt / equity	0.06
Free cash flow	USD 2.6B (Q1 2026, record); 5.52B (FY2025)

Figures as of Q1 2026 / June 2026; sourced from AMD IR/SEC filings, GuruFocus, StockAnalysis, and FinanceCharts.

The bottom line

The tension is unusually clean: AMD is one of the best-executing, fastest-growing large-cap semiconductor businesses, with a fortress balance sheet and management whose customers (OpenAI, Meta) are reportedly forecasting demand above the company's own 2027 plan — yet the stock trades at roughly 60–70x forward earnings, near 33x tangible book, with most fair-value estimates clustering well below the current price. What would tip it bullish is durable evidence that ROCm is closing the CUDA gap and that GPU share is crossing into double digits, validating the growth multiple; what would tip it bearish is any deceleration, margin plateau, or hyperscaler shift toward custom silicon that exposes how little room the valuation leaves for error. The recent ~10% pullback from the USD 546 high was largely sector contagion from Broadcom's soft guidance rather than an AMD-specific crack — leaving the core question, growth versus price, unresolved.

The panel's take

Verdict: WAIT · Conviction: MEDIUM · Last price: USD 579.68 (as of 2026-06-29)

Almost the whole panel likes the business and balks at the price after a parabolic run. AMD has become a credible #2 in AI accelerators: data-center revenue hit a record $5.8B (+57%), total revenue grew ~38%, and landmark commitments — a 6-gigawatt OpenAI deployment, a reported $60B Meta supply agreement, and 50,000 MI450 GPUs for Oracle — give real revenue visibility into 2027. But the stock has run roughly 4–5x (260% over the past year, +11% in the latest week alone to a fresh high), and that's where the disagreement lives. The growth and momentum frameworks see an early-innings share-gain story against NVIDIA's near-monopoly; five-plus frameworks see a stock at ~111x forward earnings pricing near-flawless execution, with fair-value estimates clustering from the high-$200s to the low-$480s — all below the ~$580 price. Tellingly, even the analyst consensus target now sits below the current price, and the chart is a textbook late-stage parabola. The business isn't in question; the entry is. That synthesizes to WAIT.

Key levels

Key resistance starts at the ~$600 round number, then measured-move extensions near $650 and $720. Key support sits at ~$525 (the prior breakout weekly close — the first mean-reversion zone), then ~$450 (a ~38% retracement of the rally), with a deeper historical accumulation zone near $335 (the 200-week trend, far below price). The analyst consensus target spans roughly USD 320 to 700 — and notably averages near USD 470, below the current price, an unusual configuration that means the stock has run through most of Wall Street's own near-term targets.

What legendary investors think

We ran AMD past a panel of six legendary investors' frameworks.

Where they agree — and where they clash

Common ground

• The AI-accelerator business is real and accelerating: data-center revenue +57% to a record $5.8B, total revenue +38%, record free cash flow, and a clean balance sheet.
• The hyperscaler commitments (OpenAI 6 GW, Meta, Oracle) are structured deals with deployment timelines, not vaporware — genuine demand visibility into 2027.
• The valuation is extended: ~111x forward earnings after a ~4–5x run, with the analyst consensus target itself now below the price.
• The chart is parabolic and overbought (weekly RSI in the high-70s/low-80s), with low short interest meaning little squeeze fuel left.

The real debate

• Early innings or priced-in? The growth and momentum lenses see an S-curve share-gain story with years to run; the valuation lenses see four years of flawless execution already embedded at ~111x forward.
• Is the moat closing or still wide? The bull cites ROCm design wins and dual-sourcing demand; the Moat Compounder and Forensic Skeptic note CUDA still holds ~85% share and ROCm only targets parity by year-end on AMD's own roadmap.
• What about the warrants? The OpenAI deal anchors demand but grants up to ~10% dilution on deployment milestones — a structure the bears say the Street's EPS math doesn't fully reflect.

The question it comes down to: Is AMD an early-stage AI-accelerator winner whose OpenAI/Meta/Oracle deals justify paying up even after a 4–5x run — or a perennial #2 at ~111x forward earnings, priced for share gains, margin expansion, and warrant-diluted execution all going right at once, with Wall Street's own targets already below the price?

The numbers

Metric	Value
Price / Market cap	USD 579.68 / ~940B
P/E (TTM / fwd)	~145–171x (GAAP/TTM) / ~111x (forward non-GAAP)
ROE	~8% (depressed by Xilinx goodwill/intangibles)
Operating margin	~25% (non-GAAP) / ~12% (GAAP)
Dividend yield	0% (no dividend)
Debt / equity	~0.06x (net cash)
Free cash flow	~USD 8.6B (TTM; record ~$2.6B in Q1 2026)

Figures as of Q1 2026 / June 2026; sourced from AMD IR/SEC filings, StockAnalysis, GuruFocus, MarketBeat. GAAP earnings are weighed down by Xilinx-acquisition intangibles, so non-GAAP figures are shown alongside; on a non-GAAP forward basis the PEG is ~1.3, but that assumes 80–90% EPS growth is sustainable — the crux of the valuation debate. The OpenAI warrant (up to ~160M shares) is a dilution factor not fully reflected in per-share consensus.

The bottom line

AMD is the rare name where nearly every framework respects the company and questions the quote. The bull case is concrete and accelerating: a credible #2 AI accelerator with data-center revenue up 57%, a 6-gigawatt OpenAI deployment, reported Meta and Oracle commitments, EPYC taking server share from Intel, and record free cash flow — a structural challenge to NVIDIA's near-monopoly that, if even partly realized, supports a far larger AI franchise. The caution is equally concrete and, after the run, dominant: at ~111x forward earnings the stock has risen ~4–5x and now trades above the average analyst target, ROE sits near 8% with GAAP operating margins around 12%, CUDA still holds the large majority of the market while ROCm only targets parity, insiders have sold heavily, the OpenAI warrants embed real dilution, and five-plus independent fair-value estimates land between the high-$200s and low-$480s — all beneath the ~$580 price — against a textbook late-stage parabolic chart. What would tip the synthesis bullish is execution that grows into the price — the MI450 ramp delivering on schedule, AI-GPU revenue scaling toward the mid-teens of billions, and margins climbing without the warrant dilution overwhelming per-share gains. What keeps it a wait is that, after a vertical move, the price already assumes most of that goes right, leaving little room for the one-quarter slip that semiconductors so often deliver — and the panel's value voices would rather own a genuinely strong business at the $350–480 zone their analysis points to than chase the parabola here.

The panel's take

Verdict: WAIT · Conviction: MEDIUM · Last price: USD 557.89 (as of 2026-07-11)

AMD is the panel's clearest "the story is real, the price has run past it" call. The fundamental case is no longer speculative: Q1 2026 revenue grew 38% to $10.25B, Data Center revenue jumped 57% to a record $5.78B, and AMD has landed genuine hyperscaler commitments — OpenAI's 6GW, Meta's ~$60B multi-year MI450 deal, and Oracle's 50,000-GPU order — that establish it as a credible second source to Nvidia rather than an also-ran. The balance sheet is pristine (net cash, record $2.6B Q1 free cash flow). But the stock has tripled in roughly three months to $557.89, and the valuation has sprinted far ahead of even the bullish fundamentals: ~179x trailing and 63x forward earnings on an 8% ROE, with the average analyst target ($518) now sitting below the current price even after a wave of upgrades, and the panel's DCF fair values clustering at $350-420. That is why three lenses are outright bearish on valuation, one is neutral, and even the two bulls — the innovation and macro lenses — explicitly want a pullback before adding. The technical picture is a strong but overextended parabola, stretched far above trend. With the fundamental thesis intact and improving but the price above every fair-value estimate on the panel, the synthesis is WAIT.

Key levels

Key resistance sits just overhead at the ~$575 round number near the recent high, then ~$600, with a measured-move extension near ~$650. Key support sits at ~$520 (the rising short-term average), then a ~$429 prior-swing shelf that would be the first real pullback zone, with the major structural floor back near the ~$200 base the entire move launched from. The analyst consensus target spans an enormous USD 250 to 700 — averaging near USD 518, which now sits below the current price even after aggressive hikes (Goldman to $640, Cantor to $700). A below-spot average target after a 3x run is the market's own signal that price has, for now, outrun the Street.

What legendary investors think

We ran AMD past a panel of six legendary investors' frameworks.

Where they agree — and where they clash

Common ground

• The AI wins are real and specific: OpenAI 6GW, Meta ~$60B, Oracle 50K MI450 GPUs — genuine second-source validation, with Data Center +57%.
• The balance sheet is excellent: net cash, record $2.6B Q1 free cash flow.
• The valuation is extreme: ~179x trailing / ~63x forward on an 8% ROE, with the average analyst target now below the price.
• Even the bulls want a pullback: the innovation and macro lenses like the thesis but not the entry after a 3x run.

The real debate

• Second source or Nvidia's equal? The innovation lens sees a durable share-gain story; the forensic lens sees a volume winner stuck at ~55% gross margin against Nvidia's ~75%.
• Priced for growth or for perfection? The macro/innovation lenses ride the trend; the value and valuation lenses say the price already discounts flawless 2027 execution.
• How much does ROCm matter? Software maturation is the swing factor for whether AMD keeps share or stays cyclical.

The question it comes down to: AMD has genuinely won a seat at the AI-accelerator table — but at ~$558, above the average analyst target and every fair-value estimate on the panel, is the question whether to own the business or whether to wait for a price that reflects it?

The numbers

Metric	Value
Price / Market cap	USD 557.89 / ~906B
P/E (TTM / fwd)	~179x / ~63x (vs ~116x trailing-average)
Q1 2026 revenue	USD 10.25B (+38% YoY); Data Center $5.78B (+57%), Client & Gaming $3.6B (+23%)
Q2 2026 guide	~$11.2B (+46% YoY), gross margin ~56%
ROE / gross margin	~8% / ~55% non-GAAP (vs Nvidia ~75%)
AI accelerators	OpenAI 6GW · Meta ~$60B/5yr · Oracle 50K MI450; Nvidia still ~80-90% share
Balance sheet	Net cash (cash ~$12.3B vs debt ~$3.2B); record Q1 FCF $2.6B; no dividend

Figures as of Q1 2026 (reported May 5, 2026) / July 11, 2026; sourced from AMD IR/SEC filings, StockAnalysis, GuruFocus, MacroTrends, TheStreet, Techi. The hyperscaler commitments (OpenAI 6GW, Meta ~$60B, Oracle 50K MI450) are real, but AMD remains a second source — Nvidia holds ~80-90% AI-accelerator share and a ~20-point gross-margin lead. Valuation is extreme (~179x trailing / ~63x forward on 8% ROE), and the average analyst target ($518) sits below the price after a 3x, three-month run. Catalysts: "Advancing AI 2026" event July 22-23; Q2 earnings ~Aug 4, 2026.

The bottom line

AMD is the panel's most extended WAIT — a company that has genuinely earned its place in the AI-accelerator race, wrapped in a stock that has already priced years of flawless execution. The bull case is real and concrete: revenue up 38%, Data Center up 57% to a record, a pristine net-cash balance sheet, and marquee commitments from OpenAI, Meta, and Oracle that make AMD a credible second source to Nvidia — which is why the innovation lens holds a high-conviction five-year view. But the panel's caution is equally concrete and, at this price, decisive: after tripling in roughly three months the stock trades at ~179x trailing and ~63x forward earnings on an 8% ROE, above the average analyst target and above every fair-value estimate on the panel ($350-420), while still carrying a ~20-point gross-margin gap to Nvidia. Tellingly, even the two bulls say the same thing as the bears about the entry — wait for a pullback. What would tip the call bullish is either the price digesting back toward the $420-520 zone or the fundamentals catching up — MI450 benchmarks at the July 22-23 event and an Aug 4 print proving durable share and margin expansion. What keeps it a wait is that, right now, buyers are paying a price the Street's own average target no longer supports for a business still fighting Nvidia's moat — the AI seat is won, but the entry is the issue.

The panel's take

Verdict: WAIT · Conviction: MEDIUM · Last price: USD 495.76 (as of 2026-07-18)

What changed since 2026-07-11:

• Price: USD 557.89 → 495.76 (-11.1%) — an 11% weekly reversal off the $574 marginal high, closing below the flattening ~$520 trend line.
• Panel: 2 of 6 → 1 of 6 now Bullish (The Macro Opportunist flipped from Bullish to Neutral) — the technical damage from the reversal outweighed fundamentals that didn't move.
• Trigger: the Advancing AI event (July 22-23) and the Q2 print (~Aug 4), both still ahead.
• Verdict: WAIT (unchanged)

AMD's fundamental story hasn't moved this week — the same 8% ROE and hyperscaler commitments, the same Q1 print — only the price did. Five of six lenses read the drop as valuation digestion rather than thesis break: the forward multiple has compressed from ~63x to ~56x on that unchanged ROE, but the panel's DCF and owner-earnings estimates still cluster at $350-420, leaving a 20-40% gap even after the pullback.

Key levels

Key resistance sits at the flattened ~$520 average, extending to a $520-525 reclaim zone, with the $574 high marking a historical resistance zone from this week's rejection. Key support begins near ~$460, then a ~$420 shelf that lines up with the panel's DCF-based fair-value range, with ~$350 marking the low end of that same historical accumulation zone. The analyst consensus target spans USD 250 to 700, averaging near USD 518 — a level the stock now trades just below, a reversal from last week when price sat above the average target.

What legendary investors think

We ran AMD past a panel of six legendary investors' frameworks.

Where they agree — and where they clash

Common ground

• The hyperscaler story is real and unchanged: OpenAI 6GW, Meta ~$60B, Oracle 50,000 MI450 GPUs, Data Center revenue +57% YoY — no lens disputes the fundamentals.
• Valuation remains the constraint: ~56x forward earnings on an 8% ROE, 20-40% above the panel's $350-420 DCF / owner-earnings range even after the drop.
• Two live catalysts are on deck and every lens wants them to resolve first: the Advancing AI event (July 22-23) and the Q2 print (~Aug 4).
• Even the lone bull sets a condition rather than buying outright: the innovation lens wants the $460 low to hold before treating this as confirmed.

The real debate

• Has the pullback done enough valuation work? The Disruptive-Innovation Seeker reads the multiple compression from ~63x to ~56x as the valuation catching up to the growth curve, while the Moat Compounder, the Intrinsic-Value Modeler, and the Forensic Skeptic still see a 20-40% gap to fair value.
• Healthy reset or warning sign? The Innovation lens treats the flattening line at $520 as noise to look through toward the next catalysts; the Forensic Skeptic and Macro Opportunist read the same close below $520 as technical damage that argues for caution.
• Wait for the catalyst, or use the pullback now? The GARP Operator and Macro Opportunist want the Advancing AI event and Q2 print to resolve before deciding; the Innovation lens is already leaning toward the weakness holding up.

The question it comes down to: with the AI story unchanged and two live catalysts nine and eighteen days out, does the multiple's compression from ~63x to ~56x forward earnings already reflect a fair price for the growth, or does the remaining 20-40% gap to the panel's $350-420 DCF range mean the pullback has further to run toward the $420-460 zone?

The numbers

Metric	Value
Price / Market cap	USD 495.76 / n/a
P/E (TTM / fwd)	n/a / ~56x
ROE	~8%
Operating margin	n/a
Dividend yield	0% (no dividend)
Debt / equity	n/a
Free cash flow	USD 2.6B (Q1 2026, record)

Fundamentals as of Q1 2026 (reported May 5, 2026) — no new print has landed since, per the panel's own read that "nothing new happened, only the price did." Price and valuation multiples as of July 18, 2026. Next scheduled catalysts: the Advancing AI event, July 22-23, 2026, and Q2 2026 earnings, ~August 4, 2026.

The bottom line

What would tip the call bullish: the Advancing AI event (July 22-23) delivering concrete MI450 benchmarks, or the August 4 print confirming durable Data Center share and margin expansion. What would tip it bearish: a close that breaks the ~$460 level, which the macro lens flags as the line for a genuine trend break rather than a routine pullback. Barring either, the value-oriented lenses see the price continuing to digest toward the $420-460 zone as the more likely near-term path before the panel reconsiders. The panel reconvenes once both catalysts resolve, whichever direction they push the multiple.